bluebird bio Inc (NASDAQ:BLUE)

104.85
Delayed Data
As of Sep 13
 +1.74 / +1.69%
Today’s Change
87.49
Today|||52-Week Range
163.43
+5.70%
Year-to-Date

Today’s Trading

Previous close103.11
Today’s open102.64
Day’s range102.19 - 107.36
Volume818,615
Average volume (3 months)565,136
Market cap$5.8B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)-38.50%
Earnings growth (this year)-26.44%
Earnings growth (next 5 years)-64.66%
Revenue growth (last year)+54.06%
P/E ratioNM
Price/Sales94.57
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
MRNAModerna Inc+0.31+1.89%
TECHBio-Techne Corp+1.03+0.52%
BPMCBlueprint Medicines ...-0.06-0.08%
ONCESpark Therapeutics I...-0.88-0.83%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)-$3.52
Annual revenue (last year)$54.6M
Annual profit (last year)-$555.6M
Net profit margin-1,018.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating &
Legal Officer
Jason F. Cole
Corporate headquarters
Cambridge, Massachusetts

Forecasts